SARS-CoV-2 pandemic in New York metropolitan area: the view from a major urgent care provider

  1. Madhura S. Rane
  2. Angela Profeta
  3. Emily Poehlein
  4. Sarah Kulkarni
  5. McKaylee Robertson
  6. Chris Gainus
  7. Ashish Parikh
  8. Kerry LeBenger
  9. Daniel Frogel
  10. Denis Nash

Reviewed by

Read the full article See related articles

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.annepidem.2022.05.006
  2. ScreenIT

    SciScore for 10.1101/2021.04.06.21255009: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementIRB: Ethical Review: This study was approved by the Institutional Review Board of the City University of New York Graduate School of Public Health and Health Policy.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    We plotted the cumulative number of individuals with any positive SARS-CoV-2 diagnostic or serologic test (PCR, antigen, antibody) during the study period to assess the total number of individuals with evidence of current or prior SARS-CoV-2 infection at the time of clinic visit.
    antigen,
    suggested: None

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    Our study has limitations. Our data only includes individuals who sought a COVID-19 test. Patients who seek care at CityMD are not representative of all persons testing for SARS-CoV-2 in the NY metropolitan area or the general population. Because CityMD is an ambulatory care provider, we did not have information on clinical evaluation and testing outside of CityMD, subsequent development of severe disease, hospitalization, or death after the visit. Typical COVID-19 symptoms were not captured in a standardized form in the EMR and could not be analyzed. In summary, our results highlight the vital role that urgent care providers play in evaluating, diagnosing and treating substantial numbers and proportions of patients for COVID-19, and in triggering self-isolation, contact tracing and helping to limit onward spread especially in population-dense, urban epicenters. CityMD may have limited the flow of less severe patients to emergency departments of hospitals, which was of critical importance during periods of surge. Also, early identification of cases in urgent care centers results in early interventions which could lead to lower morbidity. Future pandemic preparedness plans should leverage urgent care providers for a multitude of critical implementation roles with the potential to improve individual and public health outcomes.

    Results from TrialIdentifier: No clinical trial numbers were referenced.

    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

    Results from JetFighter: We did not find any issues relating to colormaps.

    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  3. Version published to 10.1101/2021.04.06.21255009v3 on medRxiv
  4. Version published to 10.1101/2021.04.06.21255009v2 on medRxiv
  5. Version published to 10.1101/2021.04.06.21255009v1 on medRxiv